# Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma

> **NCT04918940** · NA · COMPLETED · sponsor: **Centre Henri Becquerel** · enrollment: 20 (actual)

## Conditions studied

- Follicular Lymphoma
- Mantle Cell Lymphoma

## Interventions

- **BIOLOGICAL:** Determination of COVID-19 vacciantion efficacy

## Key facts

- **NCT ID:** NCT04918940
- **Lead sponsor:** Centre Henri Becquerel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-21
- **Primary completion:** 2022-06-27
- **Final completion:** 2022-06-27
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918940, "Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04918940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*